Pandemic Taking Its Toll On The US FDA’s Non-Pandemic Work, Alkermes CEO Says

 
• By Derrick Gingery

Last year was not the greatest performance by the agency outside of COVID-19, Richard Pops tells BIO conference.

Richard Pops says the advisory committee system is broken and problems are made worse with virtual meetings.

More from US FDA Performance Tracker

More from Regulatory Trackers